Classical Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Classical Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087) [Phase 2]
Results from the Phase 2 MK-3475-087 (KEYNOTE-087) study of pembrolizumab in relapsed or refractory classical Hodgkin lymphoma have been com…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) [Phase 2]
A Phase 2 study evaluating the safety and efficacy of pembrolizumab in combination with chemotherapy for newly diagnosed classical Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL [Phase 2]
Phase 2 trial evaluating AZD4573 as monotherapy or in combination for relapsed/refractory peripheral T-cell lymphoma and relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation [EARLY_Phase 1]
A phase 1 pilot trial evaluating pembrolizumab for relapse after allogeneic stem cell transplantation in patients with classical Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]
Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: An Open, Multicenter Phase II Study to Evaluate the Safety and Efficacy of KL-A167 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma [Phase 2]
Phase II study assessing KL-A167 injection for safety and efficacy in relapsed or refractory classical Hodgkin's lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Combination of Nivolumab and DHAP in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (Nivo-DHAP) [Phase 2]
A Phase 2 trial assessing the combination of nivolumab with DHAP in relapsed or refractory classical Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial investigating umbralisib and pembrolizumab in relapsed or refractory classical Hodgkin lymphoma was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating consolidation with nivolumab plus brentuximab vedotin after autologous stem cell transplant in high-risk classical …
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's Lymphoma [Phase 2]
Phase 2 multi-center randomized study evaluating AK105 in combination with Anrotinib Hydrochloride for recurrent/refractory classical Hodgki…
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL) [Phase 3]
Phase 3 trial comparing GLS-010 monotherapy to chemotherapy in relapsed or refractory classical Hodgkin's lymphoma is in progress with unkno…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL [Phase 2]
Phase 2 trial evaluating a PD-1 inhibitor alone or in combination with GVD for relapsed/refractory classical Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma [Phase 3]
Phase III clinical trial update for Penpulimab in relapsed and refractory classical Hodgkin's lymphoma (NCT05244642).
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating response-based therapy guided by PET imaging for bulky stage I/II classical Hodgkin lymphoma; study completed with …
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma [Phase 2]
Phase II study of oral panobinostat in adults with relapsed/refractory classical Hodgkin's lymphoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin [Phase 2]
Phase 2 trial update for bendamustine in patients with classical Hodgkin lymphoma treated with prednisone, vinblastine, and doxorubicin.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 3]
Phase 3 trial comparing camrelizumab to chemotherapy in relapsed/refractory classical Hodgkin lymphoma is underway with status not reported.
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating efficacy and safety of IBI308 in relapsed/refractory classical Hodgkin's lymphoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: A Study of Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 2]
Phase 2 study of Tislelizumab as monotherapy in relapsed or refractory classical Hodgkin lymphoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma [Phase 2]
Phase II study evaluating safety and efficacy of TQB2450 injection in relapsed or refractory classical Hodgkin's lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma [Phase 2]
Phase 2 trial update on combining nivolumab and brentuximab vedotin in untreated Hodgkin lymphoma in older patients; the study is active-not…
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT) [Phase 2]
Phase 2 trial evaluating Brentuximab Vedotin as an alternative to autologous stem cell transplantation in relapsed/refractory classical Hodg…
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma [Phase 2]
Phase 2 trial investigating PET-directed therapy using pembrolizumab plus combination chemotherapy for previously untreated classical Hodgki…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial update for GLS-010 Injection in Classical Hodgkin's Lymphoma.
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. [Phase 2]
Phase 2 trial evaluating combination chemotherapy with or without bortezomib in patients with recurrent or refractory classical Hodgkin lymp…